These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 20080139)

  • 1. Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: programmed endosomal escape and dissociation.
    Akita H; Kogure K; Moriguchi R; Nakamura Y; Higashi T; Nakamura T; Serada S; Fujimoto M; Naka T; Futaki S; Harashima H
    J Control Release; 2010 May; 143(3):311-7. PubMed ID: 20080139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reprint of: Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: Programmed endosomal escape and dissociation.
    Akita H; Kogure K; Moriguchi R; Nakamura Y; Higashi T; Nakamura T; Serada S; Fujimoto M; Naka T; Futaki S; Harashima H
    J Control Release; 2011 Jan; 149(1):58-64. PubMed ID: 20826039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo.
    Hatakeyama H; Ito E; Akita H; Oishi M; Nagasaki Y; Futaki S; Harashima H
    J Control Release; 2009 Oct; 139(2):127-32. PubMed ID: 19540888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Octaarginine- and pH sensitive fusogenic peptide-modified nanoparticles for liver gene delivery.
    Khalil IA; Hayashi Y; Mizuno R; Harashima H
    J Control Release; 2011 Dec; 156(3):374-80. PubMed ID: 21864599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced gene expression by a novel stearylated INF7 peptide derivative through fusion independent endosomal escape.
    El-Sayed A; Masuda T; Khalil I; Akita H; Harashima H
    J Control Release; 2009 Sep; 138(2):160-7. PubMed ID: 19465073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transfection activity of R8-modified nanoparticles and siRNA condensation using pH sensitive stearylated-octahistidine.
    Toriyabe N; Hayashi Y; Harashima H
    Biomaterials; 2013 Jan; 34(4):1337-43. PubMed ID: 23141897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Octaarginine-modified multifunctional envelope-type nano device for siRNA.
    Nakamura Y; Kogure K; Futaki S; Harashima H
    J Control Release; 2007 Jun; 119(3):360-7. PubMed ID: 17478000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A DNA microarray-based analysis of immune-stimulatory and transcriptional responses of dendritic cells to KALA-modified nanoparticles.
    Akita H; Ishii S; Miura N; Shaheen SM; Hayashi Y; Nakamura T; Kaji N; Baba Y; Harashima H
    Biomaterials; 2013 Nov; 34(35):8979-90. PubMed ID: 23968857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endosomal escape and the knockdown efficiency of liposomal-siRNA by the fusogenic peptide shGALA.
    Sakurai Y; Hatakeyama H; Sato Y; Akita H; Takayama K; Kobayashi S; Futaki S; Harashima H
    Biomaterials; 2011 Aug; 32(24):5733-42. PubMed ID: 21605898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient short interference RNA delivery to tumor cells using a combination of octaarginine, GALA and tumor-specific, cleavable polyethylene glycol system.
    Sakurai Y; Hatakeyama H; Akita H; Oishi M; Nagasaki Y; Futaki S; Harashima H
    Biol Pharm Bull; 2009 May; 32(5):928-32. PubMed ID: 19420766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KALA-modified multi-layered nanoparticles as gene carriers for MHC class-I mediated antigen presentation for a DNA vaccine.
    Shaheen SM; Akita H; Nakamura T; Takayama S; Futaki S; Yamashita A; Katoono R; Yui N; Harashima H
    Biomaterials; 2011 Sep; 32(26):6342-50. PubMed ID: 21658761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multifunctional envelope-type nanodevice for use in nanomedicine: concept and applications.
    Nakamura T; Akita H; Yamada Y; Hatakeyama H; Harashima H
    Acc Chem Res; 2012 Jul; 45(7):1113-21. PubMed ID: 22324902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymer nanoparticles for enhanced immune response: combined delivery of tumor antigen and small interference RNA for immunosuppressive gene to dendritic cells.
    Heo MB; Cho MY; Lim YT
    Acta Biomater; 2014 May; 10(5):2169-76. PubMed ID: 24394635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic delivery of siRNA to tumors using a lipid nanoparticle containing a tumor-specific cleavable PEG-lipid.
    Hatakeyama H; Akita H; Ito E; Hayashi Y; Oishi M; Nagasaki Y; Danev R; Nagayama K; Kaji N; Kikuchi H; Baba Y; Harashima H
    Biomaterials; 2011 Jun; 32(18):4306-16. PubMed ID: 21429576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A lipid nanoparticle for the efficient delivery of siRNA to dendritic cells.
    Warashina S; Nakamura T; Sato Y; Fujiwara Y; Hyodo M; Hatakeyama H; Harashima H
    J Control Release; 2016 Mar; 225():183-91. PubMed ID: 26820519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell penetrating peptide-mediated systemic siRNA delivery to the liver.
    Hayashi Y; Yamauchi J; Khalil IA; Kajimoto K; Akita H; Harashima H
    Int J Pharm; 2011 Oct; 419(1-2):308-13. PubMed ID: 21827843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronic acid controls the uptake pathway and intracellular trafficking of an octaarginine-modified gene vector in CD44 positive- and CD44 negative-cells.
    Yamada Y; Hashida M; Harashima H
    Biomaterials; 2015 Jun; 52():189-98. PubMed ID: 25818425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stearylated INF7 peptide enhances endosomal escape and gene expression of PEGylated nanoparticles both in vitro and in vivo.
    El-Sayed A; Masuda T; Akita H; Harashima H
    J Pharm Sci; 2012 Feb; 101(2):879-82. PubMed ID: 22086751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multifunctional envelope-type nano device for novel gene delivery of siRNA plasmids.
    Moriguchi R; Kogure K; Akita H; Futaki S; Miyagishi M; Taira K; Harashima H
    Int J Pharm; 2005 Sep; 301(1-2):277-85. PubMed ID: 16019173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advantages of ethanol dilution method for preparing GALA-modified liposomal siRNA carriers on the in vivo gene knockdown efficiency in pulmonary endothelium.
    Kusumoto K; Akita H; Santiwarangkool S; Harashima H
    Int J Pharm; 2014 Oct; 473(1-2):144-7. PubMed ID: 24998506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.